Avoro Capital Advisors LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 13 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$2,545,000
-3.2%
6,000,0000.0%0.15%
+25.6%
Q3 2018$2,628,000
+0.4%
6,000,0000.0%0.12%
+19.8%
Q2 2018$2,618,000
-5.6%
6,000,0000.0%0.10%
-23.5%
Q1 2018$2,772,000
+9.6%
6,000,0000.0%0.13%
-19.5%
Q4 2017$2,530,000
+0.2%
6,000,0000.0%0.16%
-16.3%
Q3 2017$2,526,000
+35.9%
6,000,0000.0%0.20%
-16.6%
Q2 2017$1,859,000
+12.6%
6,000,0000.0%0.24%
+11.4%
Q1 2017$1,651,000
+11.6%
6,000,0000.0%0.21%
-29.4%
Q4 2016$1,479,000
-27.9%
6,000,000
-14.3%
0.30%
-16.9%
Q3 2016$2,050,000
+37.9%
7,000,0000.0%0.36%
+9.1%
Q2 2016$1,487,0007,000,0000.33%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2016
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 2,000,000$36,0000.00%
Bruce & Co., Inc. 2,000,000$10,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders